NL

Nigel Lange

Oncosil Medical Limited | Chief Executive Officer, Managing Director
Mr Lange has over 40 years of experience in the medical devices industry. Since 2003, Nigel has held various leadership roles with Sirtex Medical. From 2003, Nigel served as Chief Executive Officer of Sirtex's European business, responsible for establishing their brachytherapy device in over 300 centers across Europe and the Middle East. Since 2017, Nigel served as Group Chief Commercial Officer where he was responsible for all commercial aspects of global business. During this time, Nigel has also held interim roles including Interim Group CEO and Interim CEO of Asia Pacific. He is a member of the Risk Committee.

Company and Roles

Company
Title
Tenure
Since
OSL
OSL
Oncosil Medical Limited
  • Chief Executive Officer
  • Managing Director
5yrs, 8mthJan 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OSL
OSL
Oncosil Medical Limited
30/06/26106,789N/A190,187N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OSL
OSL
Oncosil Medical Limited
17/03/26
Issued
103,039$0.550$56,671Placement
OSL
OSL
Oncosil Medical Limited
17/03/26
Expiry
14,296$0.550$7,862As advised by the company
OSL
OSL
Oncosil Medical Limited
17/03/26
Expiry
7,105$0.550$3,907As advised by the company
OSL
OSL
Oncosil Medical Limited
17/03/26
Issued
73,530$0.550$40,441Issue of options
OSL
OSL
Oncosil Medical Limited
01/12/25
Issued
114,157$1.112$126,999Director remuneration